Key HighlightsThe backdrop against which these eight companies are trading in September 2026 is one of selective investor appetite rather than broad enthusiasm. UK-listed healthcare and life-sciences businesses, particularly at the smaller end, have spent much of the post-pandemic period contending with tighter financing …
Key HighlightsSmith & Nephew plc (LSE:SN.) opened September in theDebtmarket rather than theEquitymarket. On 9 September 2026 the FTSE 100 medical technology group priced US$700 million of 5.750% notes due 11 September 2036, confirming the deal to theLondon Stock Exchangethe next morning.The operating backdrop …
Eco Animal Health Group plc — LSE:EAH closed 0.95% lower on10 September 2026, with the shares at 102.02p after a decline of 0.98p on the day.
GSK plc — LSE:GSK closed 0.69% lower on10 September 2026, with the shares at 1,791.00p after a decline of 12.50p on the day.
Optima Health plc — LSE:OPT closed 0.14% higher on10 September 2026, with the shares at 246.83p after a gain of 0.33p on the day.
Anpario plc — LSE:ANP closed 2.97% lower on10 September 2026, with the shares at 465.75p after a decline of 14.25p on the day.
Cizzle Biotechnology Holdings plc — LSE:CIZ closed 2.90% higher on10 September 2026, with the shares at 1.49p after a gain of 0.04p on the day.
The question ahead of full-year results on 26 October 2026 is whether that neurology pipeline can grow fast enough to offset currency headwinds, pricing pressure in China and a troponinFranchisethat has yet to deliver.
The rescue arrived alongside a new narrative: a commercial chief executive hired from Oxford Nanopore, a first paying customer for the EpiSwitch Orion platform, a UAE partner for the PSE prostate test and PSE volumes more than doubling year on year. The question is …
That obscurity is precisely why some investors hunt in this corner of the London Stock Exchange. The immediate question is whether the Ely-based group can turn improving gross margins and growth in the UK and India into a return to profitability, at a moment …